NMPA Approval

Purified Protein Derivative of Tuberculin(TB-PPD)

Approval Number

国药准字S10960018

Company北京先声祥瑞生物制品股份有限公司

Registration Date

October 30, 2020

Previous Approval Numbers

国药准字S10960018

Drug Information

Generic Name

结核菌素纯蛋白衍生物

Dosage Form

注射剂

Strength

20IU/ml.1ml/支

Drug Type

生物制品

Registration Date

October 30, 2020

Company Information

Applicant Company

Company Name北京先声祥瑞生物制品股份有限公司

Company Address

北京市怀柔区雁栖经济开发区雁栖北三街17号

Manufacturing Company

Company Name北京先声祥瑞生物制品股份有限公司

Company Address

北京市怀柔区雁栖经济开发区雁栖北三街17号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

结核菌素纯蛋白衍生物 - NMPA 批准文号 | MedPath